Folgen
Rousseau
Rousseau
CHU
Bestätigte E-Mail-Adresse bei chu-toulouse.fr
Titel
Zitiert von
Zitiert von
Jahr
ERCC1 isoform expression and DNA repair in non–small-cell lung cancer
L Friboulet, KA Olaussen, JP Pignon, FA Shepherd, MS Tsao, S Graziano, ...
New England journal of medicine 368 (12), 1101-1110, 2013
4332013
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
D Malka, P Cervera, S Foulon, T Trarbach, C de la Fouchardière, ...
The lancet oncology 15 (8), 819-828, 2014
4262014
MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer
NS Kamal, JC Soria, J Mendiboure, D Planchard, KA Olaussen, ...
Clinical cancer research 16 (4), 1206-1215, 2010
1182010
Serotonin syndrome: analysis of cases registered in the French pharmacovigilance database
D Abadie, V Rousseau, S Logerot, J Cottin, JL Montastruc, F Montastruc
Journal of clinical psychopharmacology 35 (4), 382-388, 2015
1022015
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC …
WE Pierceall, KA Olaussen, V Rousseau, E Brambilla, KM Sprott, F Andre, ...
Annals of oncology 23 (9), 2245-2252, 2012
812012
Adverse drug reactions to self‐medication: a study in a pharmacovigilance database
A Berreni, F Montastruc, E Bondon‐Guitton, V Rousseau, D Abadie, ...
Fundamental & clinical pharmacology 29 (5), 517-520, 2015
722015
Pharmacovigilance of self-medication: a review of Adverse Drug Reactions (ADRs) registered in a pharmacovigilance database
A Berreni, E Guitton, V Rousseau, D Abadie, F Montastruc, G Durrieu, ...
FUNDAMENTAL & CLINICAL PHARMACOLOGY 29, 49-50, 2015
72*2015
Evaluation of sexuality, health-related quality-of-life and depression in advanced cancer patients: a prospective study in a Phase I clinical trial unit of predominantly …
M Rouanne, C Massard, A Hollebecque, V Rousseau, A Varga, A Gazzah, ...
European Journal of Cancer 49 (2), 431-438, 2013
542013
Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer
E Vacchelli, L Galluzzi, V Rousseau, A Rigoni, A Tesniere, N Delahaye, ...
Oncoimmunology 1 (3), 271-278, 2012
492012
Completeness of spontaneous adverse drug reaction reports sent by general practitioners to a regional pharmacovigilance centre: a descriptive study
G Durrieu, J Jacquot, M Mège, E Bondon-Guitton, V Rousseau, ...
Drug safety 39 (12), 1189-1195, 2016
472016
Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting
F Montastruc, H Bagheri, I Lacroix, C Damase-Michel, L Chebane, ...
Drug safety 41 (5), 511-514, 2018
442018
Significance of TP53 mutations as predictive markers of adjuvant cisplatin‐based chemotherapy in completely resected non‐small‐cell lung cancer
X Ma, V Rousseau, H Sun, S Lantuejoul, M Filipits, R Pirker, H Popper, ...
Molecular oncology 8 (3), 555-564, 2014
442014
An original pharmacoepidemiological–pharmacodynamic method: application to antipsychotic‐induced movement disorders
TTH Nguyen, A Pariente, JL Montastruc, M Lapeyre‐Mestre, V Rousseau, ...
British journal of clinical pharmacology 83 (3), 612-622, 2017
402017
Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database
F Montastruc, C Duguet, V Rousseau, H Bagheri, JL Montastruc
European journal of clinical pharmacology 70 (9), 1123-1127, 2014
402014
Predictive Value of Susceptibility Vessel Sign for Arterial Recanalization and Clinical Improvement in Ischemic Stroke
J Darcourt, P Withayasuk, I Vukasinovic, C Michelozzi, G Bellanger, ...
Stroke 50 (2), 512-515, 2019
372019
BINGO investigators: Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, noncomparative phase 2 trial
D Malka, P Cervera, S Foulon, T Trarbach, C de la Fouchardière, ...
Lancet Oncol 15 (8), 819-828, 2014
372014
Can drugs induce or aggravate sleep apneas? A case–noncase study in VigiBase®, the WHO pharmacovigilance database
M Linselle, A Sommet, E Bondon‐Guitton, F Moulis, G Durrieu, ...
Fundamental & clinical pharmacology 31 (3), 359-366, 2017
362017
Underlying Small Vessel Disease associated with Mixed Cerebral Microbleeds
C Blanc, A Viguier, L Calviere, M Planton, JF Albucher, V Rousseau, ...
Frontiers in Neurology 10, 1126, 2019
312019
Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years
L Hauviller, F Eyvrard, V Garnault, V Rousseau, L Molinier, JL Montastruc, ...
European journal of clinical pharmacology 72 (5), 631-639, 2016
302016
Gemcitabine and oxaliplatin (GEMOX) alone or in combination with cetuximab as first-line treatment for advanced biliary cancer: Final analysis of a randomized phase II trial …
D Malka, L Fartoux, V Rousseau, T Trarbach, E Boucher, ...
Journal of Clinical Oncology 30 (15_suppl), 4032-4032, 2012
302012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20